138 related articles for article (PubMed ID: 11996908)
21. Evidence that the inhibition of TE85 human bone cell proliferation by agents which stimulate cAMP production may in part be mediated by changes in the IGF-II regulatory system.
Mohan S; Baylink DJ
Growth Regul; 1991 Sep; 1(3):110-8. PubMed ID: 1726835
[TBL] [Abstract][Full Text] [Related]
22. Regulation of insulin-like growth factor binding protein 4 by a specific insulin-like growth factor binding protein 4 proteinase in normal human osteoblast-like cells: implications in bone cell physiology.
Durham SK; Kiefer MC; Riggs BL; Conover CA
J Bone Miner Res; 1994 Jan; 9(1):111-7. PubMed ID: 7512304
[TBL] [Abstract][Full Text] [Related]
23. Elevated insulin-like growth factor (IGF) binding protein (IGFBP)-2 and IGFBP-4 expression of leukemic T-cells is affected by autocrine/paracrine IGF-II action but not by IGF type I receptor expression.
Elmlinger MW; Sanatani MS; Bell M; Dannecker GE; Ranke MB
Eur J Endocrinol; 1998 Mar; 138(3):337-43. PubMed ID: 9539310
[TBL] [Abstract][Full Text] [Related]
24. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells.
Fleming JM; Leibowitz BJ; Kerr DE; Cohick WS
J Endocrinol; 2005 Jul; 186(1):165-78. PubMed ID: 16002546
[TBL] [Abstract][Full Text] [Related]
25. Potential mechanism of estrogen-mediated decrease in bone formation: estrogen increases production of inhibitory insulin-like growth factor-binding protein-4.
Kassem M; Okazaki R; De León D; Harris SA; Robinson JA; Spelsberg TC; Conover CA; Riggs BL
Proc Assoc Am Physicians; 1996 Mar; 108(2):155-64. PubMed ID: 8705735
[TBL] [Abstract][Full Text] [Related]
26. Insulin-like growth factor-I (IGF-I) regulates IGFBP-3 and IGFBP-4 by multiple mechanisms in A549 human adenocarcinoma cells.
Price WA; Moats-Staats BM; Stiles AD
Am J Respir Cell Mol Biol; 1995 Oct; 13(4):466-76. PubMed ID: 7546777
[TBL] [Abstract][Full Text] [Related]
27. Fluoride at mitogenic doses induces a sustained activation of p44mapk, but not p42mapk, in human TE85 osteosarcoma cells.
Wu LW; Yoon HK; Baylink DJ; Graves LM; Lau KH
J Clin Endocrinol Metab; 1997 Apr; 82(4):1126-35. PubMed ID: 9100584
[TBL] [Abstract][Full Text] [Related]
28. IGFBPs modulate IGF-I- and high glucose-controlled growth of human retinal endothelial cells.
Giannini S; Cresci B; Pala L; Ciucci A; Franchini A; Manuelli C; Fujita-Yamaguchi Y; Cappugi P; Zonefrati R; Rotella CM
J Endocrinol; 2001 Nov; 171(2):273-84. PubMed ID: 11691647
[TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factor-I and epidermal growth factor regulate insulin-like growth factor binding protein-3 (IGFBP-3) in the human keratinocyte cell line HaCaT.
Wraight CJ; Werther GA
J Invest Dermatol; 1995 Oct; 105(4):602-7. PubMed ID: 7561166
[TBL] [Abstract][Full Text] [Related]
30. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells.
Sheikh MS; Shao ZM; Hussain A; Clemmons DR; Chen JC; Roberts CT; LeRoith D; Fontana JA
J Cell Physiol; 1993 Jun; 155(3):556-67. PubMed ID: 7684042
[TBL] [Abstract][Full Text] [Related]
31. The IGFBP-3 mRNA and protein levels are IGF-I-dependent and GH-independent in MG-63 human osteosarcoma cells.
Rosato R; Gerland K; Jammes H; Bataille-Simoneau N; Segovia B; Mercier L; Groyer A
Mol Cell Endocrinol; 2001 Apr; 175(1-2):15-27. PubMed ID: 11325513
[TBL] [Abstract][Full Text] [Related]
32. Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action.
McGuire WL; Jackson JG; Figueroa JA; Shimasaki S; Powell DR; Yee D
J Natl Cancer Inst; 1992 Sep; 84(17):1336-41. PubMed ID: 1379645
[TBL] [Abstract][Full Text] [Related]
33. Cellular localization and sex steroid regulation of insulin-like growth factor binding protein messenger ribonucleic acids in the primate myometrium.
Adesanya OO; Zhou J; Bondy CA
J Clin Endocrinol Metab; 1996 Jul; 81(7):2495-501. PubMed ID: 8675566
[TBL] [Abstract][Full Text] [Related]
34. Co-expression of messenger ribonucleic acids encoding IGF-I, IGF-II, type I and II IGF receptors and IGF-binding proteins (IGFBP-1 to -6) during follicular development in the ovary of seasonally anoestrous ewes.
Hastie PM; Onagbesan OM; Haresign W
Anim Reprod Sci; 2004 Aug; 84(1-2):93-105. PubMed ID: 15302390
[TBL] [Abstract][Full Text] [Related]
35. The expression of the IGF system in the bovine uterus throughout the oestrous cycle and early pregnancy.
Robinson RS; Mann GE; Gadd TS; Lamming GE; Wathes DC
J Endocrinol; 2000 May; 165(2):231-43. PubMed ID: 10810287
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the insulin-like growth factor axis in a human hepatoma cell line (PLC).
Scharf JG; Schmidt-Sandte W; Pahernik SA; Ramadori G; Braulke T; Hartmann H
Carcinogenesis; 1998 Dec; 19(12):2121-8. PubMed ID: 9886566
[TBL] [Abstract][Full Text] [Related]
37. Alterations in the synthesis of insulin-like growth factor binding proteins and insulin-like growth factors in rat C6 glioma cells transfected with a gap junction connexin43 cDNA.
Bradshaw SL; Naus CC; Zhu D; Kidder GM; D'Ercole AJ; Han VK
Regul Pept; 1993 Oct; 48(1-2):99-112. PubMed ID: 7505471
[TBL] [Abstract][Full Text] [Related]
38. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor.
Raile K; Höflich A; Kessler U; Yang Y; Pfuender M; Blum WF; Kolb H; Schwarz HP; Kiess W
J Cell Physiol; 1994 Jun; 159(3):531-41. PubMed ID: 8188767
[TBL] [Abstract][Full Text] [Related]
39. Insulin-like growth factor (IGF)-I, -II, IGF binding proteins (IGFBP)-3, -4, and -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent.
Malpe R; Baylink DJ; Linkhart TA; Wergedal JE; Mohan S
J Bone Miner Res; 1997 Mar; 12(3):423-30. PubMed ID: 9076585
[TBL] [Abstract][Full Text] [Related]
40. Coupling between phosphoinositide breakdown and early mitogenic events in fibroblasts. Studies with fluoroaluminate, vanadate, and pertussis toxin.
Paris S; Chambard JC; Pouysségur J
J Biol Chem; 1987 Feb; 262(5):1977-83. PubMed ID: 3029057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
